Condition

Neoplasm of Lung

ClinicalTrials.gov condition label

Clinical trials11
Recruiting2
Common interventions25
Lead sponsors shown10

Clinical trials

11 shown
Prehab for Lung and Esophageal CancerNCT06354959 · 2024-06-01
RECRUITING
Confocal Laser Endomicroscopy VERificationNCT06079970 · 2023-10-18
RECRUITING
Multimodalitic Imaging in the N-stage of Lung CancerNCT05840094 · 2023-05-01
UNKNOWN
Trial of NanoPac Intratumoral Injection in Lung CancerNCT04314895 · 2021-04-14
COMPLETED
Effect of Incidental Findings Information on Lung Cancer Screening IntentNCT04432753 · 2020-07-16
COMPLETED
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid BiopsiesNCT04566614 · 2020-06-18
COMPLETED
Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung SurgeryNCT04665531 · 2020-02-19
COMPLETED
Efficacy of Continous Regional Anesthesia Using m. Erector Spinae Catheter After VATS ProceduresNCT04062045 · 2019-10-14
UNKNOWN
CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical UtilityNCT03986463 · 2019-05-01
COMPLETED
9-ING-41 in Patients With Advanced CancersNCT03678883 · 2019-01-04
ACTIVE_NOT_RECRUITING
CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With NivolumabNCT03123783 · 2017-07-10
COMPLETED

Common interventions

18F-FDGDRUG19-ING-41DRUG1APX005MDRUG1Carboplatin.DRUG1Circulating tumour DNA (ctDNA)OTHER1Conventional diagnostic bronchoscopyPROCEDURE1ctDNA blood samplingOTHER1Doxorubicin.DRUG1EBUS-TBNAPROCEDURE1Erector Spinae CatheterPROCEDURE1Gemcitabine - 21 day cycleDRUG1Gemcitabine - 28 day cycleDRUG1Intercostal blockPROCEDURE1IrinotecanDRUG1LomustineDRUG1Lung Cancer Screening Decision Aid with Incidental Findings InformationBEHAVIORAL1Lung Cancer Screening Decision Aid without Incidental Findings InformationBEHAVIORAL1MR STIRDEVICE1Nab paclitaxel.DRUG1NanoPac (sterile nanoparticulate paclitaxel) Powder for SuspensionDRUG1Neelde Based Confocal Laser EndomicroscopyDEVICE1NivolumabDRUG1Paclitaxel.DRUG1PrehabilitationBEHAVIORAL1Ropivacaine 0.2% Injectable SolutionDRUG1

Trial status mix

COMPLETED6
RECRUITING2
UNKNOWN2
ACTIVE_NOT_RECRUITING1

Phase mix

NA6
PHASE23
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.